Prior authorization is one of the most talked-about friction points in American healthcare — and for good reason. It sits directly between a doctor's recommendation and a patient receiving care. Understanding how it works, why it exists, and where it creates problems helps patients advocate for themselves and set realistic expectations when navigating the system.
Prior authorization (PA) — sometimes called preauthorization or precertification — is a requirement from a health insurance plan that a provider must get approval before delivering certain treatments, medications, procedures, or referrals. Without that approval, the insurer may refuse to cover the cost.
The process typically works like this:
This review can take anywhere from a day to several weeks, depending on the insurer, the type of request, and whether it's classified as urgent or routine.
Insurers frame prior authorization as a tool to ensure treatments are medically necessary, evidence-based, and cost-appropriate. In practice, it's designed to manage utilization and cost — which means it creates benefits for the system that don't always align with benefits for individual patients.
Common categories that frequently require prior authorization include:
Not every plan requires PA for the same services. What triggers a review depends on the specific insurance plan, the patient's benefit tier, and the type of service being requested.
The most direct impact of prior authorization on patient care is delay. A physician prescribes a treatment based on their clinical judgment. That treatment then waits while paperwork is reviewed by someone who hasn't examined the patient.
Delays matter differently depending on the condition:
| Condition Type | Impact of Delay |
|---|---|
| Chronic, stable conditions | Moderate — inconvenient but often manageable |
| Acute or rapidly progressing illness | Serious — delays can worsen outcomes |
| Mental health crises | High-risk — timely access is often critical |
| Cancer treatment | Potentially severe — timing can affect treatment windows |
| Post-surgical medications or equipment | Disruptive — can stall recovery |
The clinical urgency of a situation doesn't always match the speed of the insurance review process. Most insurers have expedited review options for urgent cases, but what qualifies as "urgent" may be defined differently by each plan.
Prior authorization doesn't just delay care — it changes the shape of care in several ways.
Physicians and their administrative staff spend significant time managing PA requests. This time isn't spent with patients. In some cases, providers will prescribe a different, PA-free treatment simply to avoid the administrative hurdle — even if the original choice was clinically preferred. This is sometimes called treatment substitution, and patients may not always be aware it's happening.
A closely related policy is step therapy, sometimes called "fail first." This requires patients to try a lower-cost or more common treatment before the insurer will approve coverage for the originally prescribed option. If the first treatment doesn't work — or causes side effects — the patient must document that failure before getting access to what their doctor recommended initially.
Step therapy has a logic to it in some circumstances. But for patients with complex histories, rare conditions, or prior treatment experience, it can mean retreating through treatments that didn't work before.
When a prior authorization is denied or delayed, some patients simply don't pursue the treatment — especially for medications. This is called prescription abandonment. Cost, complexity, and frustration all contribute. The downstream effects on health outcomes depend heavily on the specific condition being untreated or under-treated.
A denial is not the final word. Patients have the right to appeal insurance decisions, and understanding that process matters.
Key steps after a denial:
The success rate of appeals varies. Appeals supported by strong clinical documentation, peer-reviewed evidence, and physician advocacy tend to fare better than those submitted without additional support. Your physician's office typically has experience navigating this — it's worth asking them to advocate directly.
Prior authorization has attracted bipartisan criticism and is increasingly under regulatory scrutiny. Several reform directions are active at different levels:
The pace and scope of reform varies significantly by state and plan type. Employer-sponsored plans, marketplace plans, Medicaid, and Medicare Advantage each operate under different regulatory frameworks.
You don't have to wait until you're caught in a delay to think about this. A few questions worth asking in advance:
Prior authorization is neither purely a cost-control scheme nor a purely neutral clinical safeguard — it's a policy mechanism with real consequences that play out differently depending on the condition, the plan, the provider, and the patient. 🩺
Some patients move through the process with minimal disruption. Others experience meaningful delays, treatment substitutions, or denials that require active navigation. The variables — plan type, condition urgency, physician experience with PA processes, and state regulations — make it impossible to predict how any individual will be affected.
What every patient can do is understand the system well enough to ask the right questions, know their appeal rights, and work with their physician when the process creates barriers to the care their doctor recommends.
